Jaksch Frank JR Buys Shares of NAGE
Jaksch Frank JR purchased 31,746 shares of NAGE on June 24, 2026.
Key Points
- Jaksch Frank JR bought 31,746 shares of NAGE on June 24, 2026, as part of recent insider transactions.
- Shares of NAGE traded near $3.42 on Saturday, with the company seeing active institutional trading.
- Analysts like HC Wainwright & Co. maintain a 'buy' rating, with a price target of $11 as of May 11, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Jaksch Frank JR recently purchased 31,746 shares of NAGE on June 24, 2026. This insider transaction is part of a series of buys by company insiders, reflecting ongoing activity within the company's leadership.
Other Institutional Activity in NAGE
Several institutional investors have been active in trading NAGE shares. BlackRock, Inc. reduced its position by 204,090 shares, leaving it with 3,871,619 shares valued at about $17.07 million. Meanwhile, SteelPeak Wealth, LLC opened a new position with 3,373,000 shares, valued at approximately $14.87 million. Arrowstreet Capital, Limited Partnership increased its holdings by 761,685 shares, ending with 2,378,437 shares worth around $10.49 million. Vanguard Capital Management LLC also opened a new position with 2,149,277 shares, valued at about $9.48 million. Tieton Capital Management, LLC increased its stake by 384,062 shares to 2,029,155 shares, valued at $8.95 million.
Niagen Bioscience, Inc. Stock Up 4.0%
Shares of NAGE traded near $3.42 on Saturday. The stock has been active with various institutional investors adjusting their positions. Although specific financial metrics like market cap and P/E ratio are not available, the company's recent trading activity suggests a dynamic interest among both institutional and insider participants.
$NAGE stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Niagen Bioscience, Inc.
On June 24, 2026, several insiders, including Jaksch Frank JR, Ng Wang Yu Gary, Cohen Ann, Patrick Kristin, Rubin Steven, and Shahbazi Hamed, each bought 31,746 shares of NAGE. These transactions were not part of any pre-planned trading schedule, indicating a direct investment interest by the company's leadership.
Analysts Set New Price Targets
Analysts continue to show interest in NAGE. On May 11, 2026, HC Wainwright & Co. maintained its 'buy' rating with a price target of $11. Canaccord Genuity also maintained a 'buy' rating with a target of $10 on May 5, 2026. The analyst consensus remains positive, with a strong buy recommendation prevailing among those tracking the stock.
Bottom Line
The recent insider purchases by Jaksch Frank JR and other executives at NAGE highlight ongoing interest and confidence from within the company. Institutional investors have also been actively trading the stock, suggesting varied strategies among major players. While the current stock price and analyst ratings reflect optimism, these 13F filings and insider transactions provide a backward-looking snapshot of investor sentiment.
Get Niagen Bioscience, Inc. alerts
New 13F filings, insider trades, and analyst moves on $NAGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.